• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • WCW HOME
  • Submit a Wire!
  • Advertising
  • Media Partners
  • About
  • Contact Us

WorkCompWire

Your Trusted Source for Workers Compensation News

Enlyte
  • Workers Compensation News
    • Workers Compensation Industry News
    • Association, Rating & Research News
    • Claims, Legal, & Compliance News
    • Legislative & Regulatory News
    • Risk Management News
    • Work Force & Human Resource News
  • Featured Articles
  • Leaders Speak
  • Editor’s Forum
  • People On The Move

NCCI Publishes 2010 Workers’ Compensation Prescription Drug Study Update

January 6, 2011 - WorkCompWire

Boca Raton, FL–Janaury 5, 2011– This newly updated NCCI study shows that the volume of prescription drugs dispensed to workers compensation claimants has risen sharply—putting upward pressure on costs.

The study is available for reading or downloading now by clicking here.

Here are some of the study highlights:

The volume of prescription drugs dispensed by physicians to workers compensation (WC) claimants has risen sharply in recent years—putting upward pressure on WC costs. This updated NCCI study investigates the increase and other issues associated with WC prescription drug (Rx) costs.

Key Findings

  • WC costs due to physician-dispensed drugs rose dramatically in 2008.
  • Three-fourths of WC repackaged drug costs originate from physicians
  • Lower than expected emergence of Rx costs has prompted us to lower our projected ultimate Rx share of total medical from 19% to 18%.
  • After two seemingly abnormal years in which price change was the dominant factor affecting per-claim WC Rx cost increases, utilization change has once again taken its historically dominant role.
  • OXYCONTIN® has become the top prescribed (in terms of paid dollars) WC Rx. A successful patent defense, which resulted in the removal of the extended release generic version of OXYCONTIN® from the market, is likely the major contributing factor.

In addition to a new look at physician-dispensed drugs, we have updated prior analyses for:

  • The prescription drug share of total medical costs by injury year
  • Changes in price, utilization, and cost
  • Prescribing patterns
  • Drug rankings by overall cost

Historical Background

Prescription drugs have been a significant driver of WC medical costs for many years. NCCI first examined WC Rx issues in 2003 and found that utilization (as opposed to price) increases were the significant force behind Rx cost increases at that time. In 2007, NCCI found that state cost differences were driven mostly by the mix of drugs prescribed (as opposed to price or number of scripts). Several drugs, such as ACTIQ® and MOBIC® have shown significant changes in market share over the course of these prior studies. For further historical details, please see our previous five studies—available for download at ncci.com.

Contact:

Greg Quinn
Director, Media Relations
NCCI Holdings, Inc
607-723-7878

Source:  NCCI

Filed Under: Industry News, Top Stories - Recent, WCW Inner Page Featured - Recent

Primary Sidebar

Get Our Free Newsletter:

Select list(s) to subscribe to


By submitting this form, you are consenting to receive marketing emails from: WorkCompWire.com, PO Box 1114, Culver City, CA, 90232, http://www.workcompwire.com. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact

myMatrixx

Paradigm

One Call

MTI

Follow Us on Twitter

Tweets by WorkCompWire

Workers Compensation News Topics

  • Top Stories
  • Featured Articles
  • Leaders Speak
  • Editor’s Forum
  • The RxProfessor
  • Industry News
  • Association, Rating & Research News
  • People On The Move
  • Claims, Legal, & Compliance News
  • Legislative & Regulatory News
  • Risk Management News
  • Work Force & Human Resource News
  • Workers’ Compensation

Wire Archives

Copyright WorkCompWire © 2023